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Computed tomography angiography-based
evaluation of great saphenous vein conduit for
lower extremity bypass
Dorian J. deFreitas, MD,a,b Timothy P. Love, MD,a,b Karthikeshwar Kasirajan, MD,c
Noel C. Haskins, MD,d,e Ronald T. Mixon, MD,d,e Luke P. Brewster, MD, PhD,a,b
Yazan Duwayri, MD,a,b and Matthew A. Corriere, MD, MS,a,b,f Atlanta, Ga; and Seattle, Wash
Objective: Lower extremity computed tomography angiography (CTA) is frequently used for anatomic assessment of lower
extremity peripheral arterial disease. When lower extremity bypass is planned, duplex ultrasound (DUS) is routinely obtained
to evaluate the great saphenous vein (GSV) for use as conduit. Although GSV can be visualized on CTA images, diameter
assessment is not routinely included in formal study interpretation. We hypothesized that CTA images could be used to
measure GSV diameters and that CTA-based diameters would correlate with measurements obtained using DUS.
Methods: Consecutive patients undergoing lower extremity arterial bypass who were evaluated preoperatively with both CTA
and DUS vein mapping were identified at a single hospital. Minimum above- and below-knee GSV diameters were measured
from electronically archived CTA images by two independent observers. CTAs were performed using standard arterial phase
protocol without additional venous phase imaging. Between-observer reproducibility of CTA-based diameter measurements
was evaluatedusing intraclass correlation coefficients.CorrelationbetweenCTAandDUS-basedGSVdiameterswas evaluated
with Spearman correlation coefficients. CTA diameter cut-points for identification of adequate GSV bypass conduit, defined
as DUS-based minimum GSV diameter > 3 mm, were determined using receiver-operating characteristic curves.
Results: Sixty-three lower extremities were evaluated in 36 patients. In the absence of previous surgical removal, GSV was
visible on all CTAs reviewed. No instances of GSV thrombosis were identified onDUS.MinimumDUS-based above-knee
GSV diameter was 2.9 0.1 mm (range, 1.4-4.6 mm), and mean below-knee diameter was 2.6 0.1 mm (range, 1.3-4.0
mm). When GSV was visible and exceeded the minimum diameter threshold for CTA measurement, correlation between
CTA- and DUS-based diameters was both positive and highly significant (  0.595; P < .0001). CTA-based diameters
also had excellent reliability between observers (r [95% CI]: 0.88 [0.85-0.91]). For identification of adequate bypass
conduit using CTA, above-knee GSV diameter > 3.9 mm was 67% sensitive and 73% specific; below-knee GSV diameter
>3.0 mm was 75% sensitive and 84% specific.
Conclusions: CTA-based GSV diameter measurements have good reproducibility and highly significant correlation with
DUS-based diameters. CTA-based GSV diameter is a specific but relatively insensitive indicator of adequate bypass
conduit. When CTA-based diameters indicate inadequate GSV bypass conduit, confirmatory DUS vein mapping is
warranted. Confirmatory DUS vein mapping may be unnecessary when adequate vein diameter is identified on CTA.
(J Vasc Surg 2013;57:50-5.)
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bPeripheral arterial disease (PAD) affects 8 million
Americans1 and is associated with costs that exceed 4 billion
U.S. dollars annually.2 Although digital subtraction con-
trast angiography is considered the gold standard for ana-
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50omic characterization of lower extremity PAD, other less
nvasive imaging techniques, such as computed tomogra-
hy angiography (CTA) and magnetic resonance angiogra-
hy have been used with increasing frequency and sug-
ested as primary modalities for localizing occlusive
esions.3 In addition to being more cost-effective than
onventional angiography,4 CTA also permits cross-
ectional evaluation of both arterial and nonarterial anat-
my, including the great saphenous vein (GSV).5 Al-
hough GSV is the preferred conduit for lower extremity
ypass and is easily visualized on cross-sectional CTA,
SV diameter assessment is not routinely included as a
art of study interpretation or reporting. Duplex ultra-
ound (DUS) is considered the standard method for
ssessment of GSV diameter6 and is usually obtained as a
eparate study to determine GSV adequacy for use as
onduit when lower extremity bypass is planned.
We hypothesized that CTA images could be used for
SV assessment for use as bypass conduit, and that CTA-
ased diameter measurements are correlated with those
btained using DUS.
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Data collection and management. This retrospective
study was conducted with approval from the Emory Uni-
versity Institutional Review Board and the Atlanta Depart-
ment of Veterans Affairs Research and Development Com-
mittee. Patients undergoing infrainguinal lower extremity
bypass at the Atlanta VA Medical Center between Novem-
ber 1, 2005 and 2010 were identified from an operative
registry, and those evaluated preoperatively with both CTA
and lower extremity DUS vein mapping were selected for
analysis. Clinical data, including patient demographic and
comorbidity characteristics, were collected from the elec-
tronic medical record.
GSV diameter measurement. DUS vein mapping
was performed in the Department of Radiology by ultra-
sound technologists. Patients were imaged in the supine
position using a 5-7 mHz Doppler ultrasound probe
(LOGIQ E9; GE Healthcare, Waukesha, Wisc). Vein di-
ameters were obtained at the following anatomic locations
for each extremity assessed: groin, proximal thigh,
midthigh, distal thigh, popliteal, proximal calf, midcalf,
distal calf, and ankle.
Lower extremity CTA imaging was performed using a
standard protocol with 1.25-mm axial cuts. GSV diameters
were measured electronically from archived images using
Philips iSite Enterprise software (Philips Healthcare, Foster
City, Calif) on standard clinical workstation computers.
CTA-based GSV diameters were evaluated from 2 cm distal
to the saphenofemoral junction to the level of the ankle and
measured from outer wall to outer wall. All CTA-based
diameters were measured from arterial and/or noncon-
trasted imaging, and additional venous phase images were
not obtained. CTA-based diameter measurements were
obtained by two independent observers, and the minimum
minor axis GSV diameters above and below the knee (de-
fined as proximal vs distal to the femoral condyles) were
recorded. Because diameters 1.7 mm could not be mea-
sured reliably fromCTA images, GSVwhich were visible on
CTA but smaller than this minimum-resolution diameter
were categorized as inadequate bypass conduit without
diameter measurement.
Statistical analysis. Descriptive statistics are displayed
as mean SD for continuous variables and number (%) for
categorical variables. Interobserver reliability of CTA-based
diameter measurements was assessed using intraclass corre-
lation coefficients based on one-way random effects
ANOVA.7,8 Correlation between CTA and DUS-based
GSV diameter measurements at above- and below-knee
anatomic locations was evaluated using Spearman correla-
tion coefficients. For categorical analyses, adequate GSV for
use as bypass conduit was defined as minimum DUS-based
diameter3.0 mm. CTA diameter cut-points for categoriza-
tion of GSV as adequate vs inadequate bypass conduit were
evaluated graphically using receiver-operating characteristic
curves, and validity of CTA-based assessment based on these
cut-points was characterized using sensitivity (true positive/
[true positive false negative]) and specificity (true negative/ Ctrue negative  false positive]). All statistical analyses were
onducted using SAS v. 9.2 (SAS Institute, Inc, Cary, NC).
ESULTS
Preoperative anatomic assessment before lower ex-
remity bypass with both lower extremity CTA and DUS
ein mapping was performed on 63 lower extremities in
6 patients during the study period. All patients were
ale with a mean age of 60.9  7.7 years and a mean
ody mass index of 27.0  4.8. Eight patients (22.2%)
ad a previous history of unilateral GSV harvest, and two
atients (5.6%) had a previous history of major lower
xtremity amputation contralateral to the anticipated
ypass. Of the 63 lower extremities studied with DUS
ein mapping, the GSV could be visualized and mea-
ured at all intended above-knee anatomic locations in
9 (93.7%) and all intended below-knee anatomic loca-
ions in 51 (90.0%). Among patients evaluated with DUS
ein mapping, all visualized GSV were compressible and
o instances of asymptomatic GSV thrombosis were
dentified. Mean GSV diameter measurements stratified
y imaging technique and anatomic location are dis-
layed in the Table. Based on DUS, mean above-knee
SV minimum diameter was 2.9  0.1 mm (range,
.4-4.6 mm), and mean below-knee minimum diameter
as 2.6  0.1 mm (range, 1.3-4.0 mm). Based on the
inimum diameter criterion of 3.0 mm, adequate GSV
ypass conduit was identified above knee in 44.4% of
xtremities and below knee in 27.9% of extremities eval-
ated with DUS.
CTA-based GSV assessments were possible in 54/59
91.5%) above-knee and 43/51 below-knee (84.3%) ana-
omic locations where DUS measurements were obtained.
ualitative characteristics that limited CTA-based GSV
isualization and measurement included lack of adipose
issue surrounding the vein and subcutaneous edema or
nflammation (Fig 1). Among CTA-based assessments,
inimum-diameter assessment was limited to categorical
esignation as inadequate because of minimum GSV diam-
ter 1.7 mm in 6/54 above-knee (11.1%) and 15/43
elow-knee (34.9%) anatomic locations. When GSV was
isible and exceeded the minimum diameter threshold for
able. GSV diameters stratified by anatomic location
natomic location
Diameter (mm)
Ultrasound CTA
roin 5.4  1.7 5.6  1.4
roximal thigh 3.4  1.1 4.3  1.7
idthigh 3.2  0.7 3.9  1.1
istal thigh 3.4  0.7 4.0  1.1
roximal calf 3.0  1.1 3.3  1.3
idcalf 3.0  1.1 2.7  0.9
istal calf 2.7  0.6 2.7  0.6
TA, Computed tomography angiography; GSV, great saphenous vein.
isplayed values represent mean SD; excludes GSVs with diameters1.7 mm.TA measurement, correlation between CTA- and DUS-
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January 201352 deFreitas et albased diameters was both positive and highly significant
(above knee:   0.482; P .001; below knee:   0.567;
P  .002). CTA-based diameters also had good reliability
between observers at both above-knee (r [95% CI]: 0.68
[0.50-0.80]) and below-knee (r [95% CI]: 0.64 [0.37-
Fig 1. Axial computed tomography angiography (CTA) images
demonstrating great saphenous vein (GSV) appearance and arti-
facts impairing diameter measurement.Arrow indicates location of
GSV. A, Normal appearance of above-knee GSV. B, Extensive
subcutaneous edema rendering vein wall indistinct. C, Paucity of
surrounding adipose tissue makes vein wall difficult to distinguish
from adjacent tibia and overlying skin and subcutaneous tissue.0.81]) locations. sBased on receiver-operating characteristic (ROC)
urve analysis, 3.9 mm was selected as the optimal above-
nee diameter cut-point indicating adequate GSV conduit
or arterial bypass (defined as DUS diameter 3.0 mm)
Fig 2, A). Below the knee, 3.0 mm was identified as the
ptimal cut-point for adequate GSV conduit for arterial
ypass (Fig 2, B). Scatterplots comparing minimum above-
nd below-knee diameters based on CTA and DUS are
ig 2. Receiver-operating characteristic curves: computed to-
ography angiography (CTA)-based minimum great saphenous
ein (GSV) diameter as indicator of adequate bypass conduit.
bove-knee (A) and below-knee (B) CTA-based diameter cut-
oints in millimeters are indicated along the curve. Adequate
onduit defined as diameter 3.0 mm by duplex ultrasound
DUS).hown in Fig 3. For identification of adequate lower ex-
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of above-knee GSV had a sensitivity of 67% and a specificity
of 73%. Below the knee, CTA-based assessment of GSV had
a sensitivity of 75% and a specificity of 84%.
DISCUSSION
Autogenous GSV is considered the conduit of choice
for lower extremity bypass when diameter is adequate.9
Assessment of GSV diameter is, therefore, an important
step in preoperative planning for lower extremity arterial
bypass, and DUS is considered the standard imaging mo-
dality for vein mapping. DUS is a noninvasive, inexpensive,
and accurate method for assessing GSV diameter6 that is
also capable of characterizing flow and identifying qualita-
tive findings, such as thrombosis or anatomic variants,
whichmay be relevant to procedural planning.10 Before the
introduction of noninvasive arterial imaging modalities,
Fig 3. Computed tomography angiography (CTA) vs
vein (GSV) diameters. Scatterplots demonstrate minim
millimeters. Solid line indicates adequate bypass cond
CTA-based diameter cut-point for above-knee (A) and bDUS represented the only widely available technique for aSV conduit assessment before lower extremity bypass.
ith increasing utilization of noninvasive cross-sectional
maging techniques, such as CTA, however, GSV anatomic
ata are now available on studies performed for arterial
ssessment but often overlooked. We retrospectively eval-
ated correlations between CTA and duplex-derived GSV
iameters and the utility of CTA-based categorical assess-
ents of GSV adequacy as bypass conduit. When GSV was
arge enough for measurement using CTA, we observed
ignificant positive correlations between CTA and DUS-
ased GSV diameters and good between-observer reliabil-
ty. We found CTA-based minimum GSV diameter to be a
pecific but relatively insensitive indicator of adequate by-
ass conduit, defined as DUS diameter 3.0 mm.
Use of CTA for assessment of GSV as conduit for lower
xtremity bypass has been described previously by Kang et
l5 in their prospective evaluation of nine patients. These
x ultrasound (DUS)-based minimum great saphenous
bove-knee (A) and below-knee (B) GSV diameters in
efinition of 3.0 mm by DUS. Dashed line indicates
-knee (B) locations.duple
um a
uit duthors observed complete agreement between CTA and
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January 201354 deFreitas et alDUS for categorizing GSV conduit as adequate vs inade-
quate based on a diameter cut-point of 2 mm. Although
they noted that CTA tends to underestimate GSV diameter
relative to DUS, a statistical evaluation of correlation be-
tween CTA and duplex-based diameters was not performed
as part of their analysis. Based on our clinical practice, we
selected a larger DUS-based diameter of 3.0 mm to define
adequate bypass conduit, potentially reducing the propor-
tion of extremities with adequate conduit, particularly be-
low the knee. Kang et al also performed their DUS vein
mapping procedures with patients positioned in the upright
or reverse Trendelenburg position; these maneuvers may
have increased vein diameters by creating lower extremity
venous distention. In contrast, we measured DUS-based
GSV diameters with patients in the supine position, which
also may have affected the proportion of patients with
adequate GSV due to assessment in a relatively non-
distended state, although this same consideration may have
facilitated diameter comparisons between imaging modali-
ties because performance of CTA with patients positioned
upright is not routinely possible on commercially available
scanners.
Because CTAs evaluated in this analysis were performed
using a standard clinical protocol, CTA-based GSV diameters
were measured from arterial phase images with veins in a
noncontrasted state. Inability to assess patency or detect
thrombus is, therefore, a potential limitation related to lack of
venous phase images; because asymptomatic GSV thrombosis
is an uncommonfinding onDUS veinmapping, however, the
significance of this disadvantage may be minimal. We suspect
that chronic GSV thrombosis ultimately results in a small,
fibrotic vein that would likely be categorized as inadequate for
use as bypass conduit by CTA-based evaluation. Although
venous phase-contrast might also improve the ability to
distinguish vein edges from surrounding soft tissues (and,
therefore, potentially reduce measurement error), routine
addition of venous phase imaging to lower extremity CTA
protocols would have the disadvantage of increasing asso-
ciated radiation exposure and therefore cannot be recom-
mended based on our data.
Because CTA was a specific but relatively insensitive
screen for adequate-diameter GSV conduit, DUS should
be obtained when lower extremity bypass is planned and
CTA-based assessment does not identify adequate bypass
conduit. Given the resolution limitations we observed with
CTA, the role of DUS vein mapping is particularly impor-
tant when vein diameter is borderline, or technical factors,
such as inflammation, edema, or paucity of surrounding
adipose tissue, impair visualization with CTA. Confirma-
tory DUS may not be necessary, however, when adequate
vein is clearly visible on CTA. DUS vein mapping is a
technique that is both time- and labor-intensive, requiring
30-45 minutes per extremity by a dedicated vascular tech-
nologist. Addition of GSV diameter measurement to rou-
tine interpretation of CTAs performed for assessment of
PAD, therefore, would potentially improve preoperative
planning by eliminating redundant DUS studies for appro-
priately selected patients, potentially benefiting resource-onstrained healthcare environments through more effi-
ient imaging utilization.
Several additional limitations of our study warrant spe-
ific discussion. First, we obtained all of our CTA measure-
ents from axial images without utilization of three-
imensional (3D) reconstructions or centerline measurement
echniques. Although measurement from axial images is
elatively straightforward and easily reproduced on desktop
orkstations from a variety of software platforms, we are
nable to comment on what additional advantages might
e gained with use of more advanced image analysis tech-
iques. Because the axial images used to perform CTA-
ased measurement are not always perpendicular to the
ong axis of the vein, oblique diameter measurements may
ave resulted in bias toward overestimation of GSV diam-
ters with CTA. We attempted to limit this effect by only
onsidering the minor axis diameters, which have been
hown to be better approximation of true centerline blood
essel measurements.11 Second, because only selected
US images were archived electronically, GSV diameters
ould only be assessed in a continuous fashion from CTA
mages. It is, therefore, possible that the anatomic location-
ased approach to DUS vein mapping, although fairly
omprehensive, may have omitted true minimum diame-
ers in some extremities and therefore biased the observed
orrelations toward the null hypothesis. Finally, we did not
valuate operative findings at the time of revascularization or
se of GSV for bypass conduit as end points for this analysis.
his decision was based on a lack of consistent criteria for the
se of vein versus synthetic conduit for lower extremity bypass
mong surgeons, particularly for above-knee distal targets,
hich would limit the validity of these end points within our
etrospective analysis. Despite these limitations, this analysis
uggests that valuable information can be gained from GSV
ssessment using CTA, and we plan further evaluation of the
tility of CTA-based assessment of lower extremity bypass
onduit with a prospective study.
ONCLUSIONS
CTA-based GSV diameter measurements are reliable
etween observers and significantly correlated with DUS-
asedmeasurements. CTA-basedGSV diameter is a specific
ut relatively insensitive indicator of adequate bypass con-
uit, and CTA-based GSV evaluation can be used for
ecisional support during preoperative planning. Confir-
atory DUS vein mapping is warranted when CTA-based
valuation does not identify adequate GSV bypass conduit,
ut it may be unnecessary when adequate diameter GSV is
isible on CTA.
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DrAhsan T. Ali (Little Rock, Ark). I congratulate the authors
for submitting this article, where Dr deFreitas and colleagues from
Emory University have addressed a practical, nonetheless an im-
portant issue. Patients requiring lower extremity bypass are rou-
tinely sent to the noninvasive vascular lab for vein mapping, which
is time consuming and costly. Their idea was to obtain information
about arterial and venous anatomy through a single imaging
modality. This has practical implications for the concept of “one-
stop” shopping.
In your methods, a retrospective review was undertaken for all
the patients that had undergone a CTA for lower extremity isch-
emia. The ones selected for revascularization then underwent a
DUS. The review took place after surgical intention had already
been performed. The diameters of the GSVwere obtained through
two independent observers for the CT and were then compared
with DUS.
It was found that there is a higher degree of correlation
between the CT measurements and the DUS in the above-knee
location and also at diameters of 3 mm and higher.
I have three questions:
(1) How many patients did NOT undergo harvest of the vein and
had a prosthetic graft instead? Thereby, the DUS and CT vein
mapping could not be confirmed? Likewise, how many did
undergo harvest of the GSV and the findings verified in the
OR?
(2) Was a 3D reconstruction used for CT vein mapping? I have
found that it gives useful anatomic information especially for
anomalies and or duplications.
(3) At your institution: Is there a protocol? Is the standard nowDr Dorian J. deFreitas. Response to question 1: We did not
nalyze intraoperative findings for a number of reasons. This is a
etrospective review and comments about the quality of the vein
ere not universally referenced in the operative notes. In addition,
here were multiple surgeons involved in patient care with no
tandard definition of what represented an adequate vein. Finally,
here was preferential use of polytetrafluoroethylene in the above-
nee location by one surgeon. I think it is important to correlate
TA-based GSV measurements with intraoperative findings to
alidate its use. This question is better addressed in a prospective
tudy where the intraoperative definition of an adequate vein and
reatment protocols are standardized.
Response to question 2: We did not use 3D reconstructions to
valuate the GSV in this study. We believed that 3D reconstructions
ould have only been beneficial in the setting of the venous phase.
his would allow us to perform central line measurements, and this
ay have helped improve the correlation between duplex and CTA.
e were able to visualize the GSV easily on the CTA, and we felt that
venous phase would have added additional radiation exposure. CTA
ffers certain advantages when evaluating the GSV. It allows for
ilateral assessment, identification of major branch points, duplicate
ystems, and visualization of the lesser saphenous vein. In addition, it
s possible to compare the distance required for arterial bypasswith the
istance of adequate saphenous vein.
Response to question 3: To date, we have only evaluated the
SV by CTA in a retrospective fashion. The next step is to perform
his prospectively. Based on our data, we would use the CTA-based
SV diameter cut points of 3.9 mm in the above-knee locations
nd 3.0 mm in the below-knee locations as a trigger points for
rdering a duplex. GSV measurements below these diameters
hould have a confirmatory duplex, and GSV with measurements
bove these diameters should be deemed adequate.
